Year |
Citation |
Score |
2020 |
Liang N, Liu L, Li P, Xu Y, Hou Y, Peng J, Song Y, Bing Z, Wang Y, Wang Y, Jia Z, Yang X, Li D, Xu H, Yu Q, ... ... Hu Z, et al. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles. Journal of Thoracic Disease. 12: 4262-4273. PMID 32944338 DOI: 10.21037/Jtd-20-1026A |
0.322 |
|
2020 |
Wang Z, Sun M, Li W, Fan L, Zhou Y, Hu Z. A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells. Frontiers in Chemistry. 8: 649. PMID 32850663 DOI: 10.3389/Fchem.2020.00649 |
0.302 |
|
2019 |
Wang Y, Wang Z, Qian Y, Fan L, Yue C, Jia F, Sun J, Hu Z, Wang W. Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics. Journal of Materials Chemistry. B. 7: 1056-1063. PMID 32254773 DOI: 10.1039/C8Tb03351J |
0.304 |
|
2019 |
Shi F, Ma Y, Qian Y, Wang Y, Wang Z, Zhao M, Hu Z. A novel peptide probe for identification of PLS3-expressed cancer cells. Analytical Chemistry. PMID 31293151 DOI: 10.1021/Acs.Analchem.9B01061 |
0.321 |
|
2019 |
Wang Y, Jia F, Wang Z, Qian Y, Fan L, Gong H, Luo A, Sun J, Hu Z, Wang W. Boosting the Theranostic effect of Liposomal Probe towards Prominin-1 through Optimized 'Dual-site Targeting'. Analytical Chemistry. PMID 30920798 DOI: 10.1021/Acs.Analchem.9B00622 |
0.304 |
|
2019 |
Cong Y, Ji L, Gao YJ, Liu FH, Cheng DB, Hu Z, Qiao ZY, Wang H. Microenvironment Induced in Situ Self-Assembly of Polymer-Peptides Conjugates that Attack Solid Tumor Deeply. Angewandte Chemie (International Ed. in English). PMID 30695128 DOI: 10.1002/Anie.201900135 |
0.323 |
|
2018 |
Wang W, Hu Z. Targeting Peptide-Based Probes for Molecular Imaging and Diagnosis. Advanced Materials (Deerfield Beach, Fla.). e1804827. PMID 30537222 DOI: 10.1002/Adma.201804827 |
0.311 |
|
2018 |
Qian Y, Wang Y, Jia F, Wang Z, Yue C, Zhang W, Hu Z, Wang W. Tumor-microenvironment controlled nanomicelles with AIE property for boosting cancer therapy and apoptosis monitoring. Biomaterials. 188: 96-106. PMID 30339943 DOI: 10.1016/J.Biomaterials.2018.10.003 |
0.316 |
|
2018 |
Zhao M, Li H, Fan L, Ma Y, Gong H, Lai W, Fang Q, Hu Z. Quantitative proteomic analysis to the first commercialized liposomal paclitaxel nano-platform Lipusu revealed the molecular mechanism of the enhanced anti-tumor effect. Artificial Cells, Nanomedicine, and Biotechnology. 1-9. PMID 30231644 DOI: 10.1080/21691401.2018.1489822 |
0.308 |
|
2018 |
Wang W, Ma Z, Zhu S, Wan H, Yue J, Ma H, Ma R, Yang Q, Wang Z, Li Q, Qian Y, Yue C, Wang Y, Fan L, Zhong Y, ... ... Hu Z, et al. Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe. Advanced Materials (Deerfield Beach, Fla.). e1800106. PMID 29682821 DOI: 10.1002/Adma.201800106 |
0.317 |
|
2018 |
Qian Y, Wang W, Wang Z, Jia X, Han Q, Rostami I, Wang Y, Hu Z. pH Triggered Peptide Self-Assembly for Targeting Imaging and Therapy towards Angiogenesis with Enhanced Signals. Acs Applied Materials & Interfaces. PMID 29439558 DOI: 10.1021/Acsami.8B00583 |
0.327 |
|
2017 |
Qiao ZY, Zhao WJ, Gao YJ, Cong Y, Zhao L, Hu Z, Wang H. Reconfigurable Peptide Nanotherapeutics at Tumor Microenvironmental pH. Acs Applied Materials & Interfaces. PMID 28828864 DOI: 10.1021/Acsami.7B09033 |
0.322 |
|
2017 |
Zhu L, Zhao Z, Cheng P, He Z, Cheng Z, Peng J, Wang H, Wang C, Yang Y, Hu Z. Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease. Advanced Materials (Deerfield Beach, Fla.). PMID 28605073 DOI: 10.1002/Adma.201700057 |
0.507 |
|
2017 |
Yang X, Wang Z, Xiang Z, Li D, Hu Z, Cui W, Geng L, Fang Q. Peptide probes derived from pertuzumab by molecular dynamics modeling for HER2 positive tumor imaging. Plos Computational Biology. 13: e1005441. PMID 28406988 DOI: 10.1371/Journal.Pcbi.1005441 |
0.324 |
|
2017 |
Jia X, Han Q, Wang Z, Qian Y, Jia Y, Wang W, Hu Z. Targeting peptide functionalized liposomes towards aminopeptidase N for precise tumor diagnosis and therapy. Biomaterials Science. PMID 28138675 DOI: 10.1039/C6Bm00898D |
0.331 |
|
2016 |
Xiang Z, Yang X, Xu J, Lai W, Wang Z, Hu Z, Tian J, Geng L, Fang Q. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide. Biomaterials. 115: 53-64. PMID 27888699 DOI: 10.1016/J.Biomaterials.2016.11.022 |
0.339 |
|
2016 |
Han Q, Wang W, Jia X, Qian Y, Li Q, Wang Z, Zhang W, Yang S, Jia Y, Hu Z. Switchable Liposomes: Targeting Peptides Functionalized and pH-Triggered Cytoplasmic Delivery. Acs Applied Materials & Interfaces. PMID 27391018 DOI: 10.1021/Acsami.6B05678 |
0.319 |
|
2016 |
Geng L, Wang Z, Jia X, Han Q, Xiang Z, Li D, Yang X, Zhang D, Bu X, Wang W, Hu Z, Fang Q. HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery. Theranostics. 6: 1261-73. PMID 27279916 DOI: 10.7150/Thno.14302 |
0.336 |
|
2016 |
Jia X, Wang W, Han Q, Wang Z, Jia Y, Hu Z. Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery. Acs Medicinal Chemistry Letters. 7: 429-34. PMID 27096054 DOI: 10.1021/Acsmedchemlett.6B00028 |
0.305 |
|
2016 |
Qian Y, Wang W, Wang Z, Han Q, Jia X, Yang S, Hu Z. Switchable probes: pH-triggered and VEGFR2 targeted peptides screening through imprinting microarray. Chemical Communications (Cambridge, England). PMID 27035754 DOI: 10.1039/C6Cc01302C |
0.307 |
|
2016 |
Rostami I, Zhao Z, Wang Z, Zhang W, Zhong Y, Zeng Q, Jia X, Hu Z. Peptide-conjugated PEGylated PAMAM as a highly affinitive nanocarrier towards HER2-overexpressing cancer cells Rsc Advances. 6: 107337-107343. DOI: 10.1039/C6Ra19552K |
0.344 |
|
2015 |
Wang W, Wang Z, Bu X, Li R, Zhou M, Hu Z. Tumor Diagnosis: Discovering of Tumor-targeting Peptides using Bi-functional Microarray (Adv. Healthcare Mater. 18/2015). Advanced Healthcare Materials. 4: 2738. PMID 26727343 DOI: 10.1002/Adhm.201570102 |
0.319 |
|
2015 |
Wang W, Wang Z, Bu X, Li R, Zhou M, Hu Z. Discovering of Tumor-targeting Peptides using Bi-functional Microarray. Advanced Healthcare Materials. PMID 26548577 DOI: 10.1002/Adhm.201500724 |
0.312 |
|
2015 |
Geng L, Wang Z, Yang X, Li D, Lian W, Xiang Z, Wang W, Bu X, Lai W, Hu Z, Fang Q. Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors. Theranostics. 5: 1154-65. PMID 26284145 DOI: 10.7150/Thno.12398 |
0.325 |
|
2015 |
Wang Z, Wang W, Bu X, Wei Z, Geng L, Wu Y, Dong C, Li L, Zhang D, Yang S, Wang F, Lausted C, Hood L, Hu Z. Microarray based Screening of Peptide Nano Probes for HER2 Positive Tumor. Analytical Chemistry. PMID 26218790 DOI: 10.1021/Acs.Analchem.5B01588 |
0.328 |
|
2015 |
Wang W, Zhang D, Wei Z, Wang Z, Bu X, Yang S, Fang Q, Hu Z. Label-free detection microarray for novel peptide ligands screening base on MS-SPRi combination. Talanta. 134: 705-11. PMID 25618725 DOI: 10.1016/J.Talanta.2014.12.012 |
0.313 |
|
2014 |
Wang W, Wei Z, Zhang D, Ma H, Wang Z, Bu X, Li M, Geng L, Lausted C, Hood L, Fang Q, Wang H, Hu Z. Rapid screening of peptide probes through in situ single-bead sequencing microarray. Analytical Chemistry. 86: 11854-9. PMID 25370073 DOI: 10.1021/Ac503454Z |
0.314 |
|
2014 |
Wang W, Li M, Wei Z, Wang Z, Bu X, Lai W, Yang S, Gong H, Zheng H, Wang Y, Liu Y, Li Q, Fang Q, Hu Z. Bimodal imprint chips for peptide screening: integration of high-throughput sequencing by MS and affinity analyses by surface plasmon resonance imaging. Analytical Chemistry. 86: 3703-7. PMID 24641070 DOI: 10.1021/Ac500465E |
0.304 |
|
2007 |
Chakravarthy MV, Zhu Y, López M, Yin L, Wozniak DF, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD, Semenkovich CF. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. The Journal of Clinical Investigation. 117: 2539-52. PMID 17694178 DOI: 10.1172/Jci31183 |
0.499 |
|
2005 |
Lane MD, Hu Z, Cha SH, Dai Y, Wolfgang M, Sidhaye A. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. Biochemical Society Transactions. 33: 1063-7. PMID 16246046 DOI: 10.1042/Bst20051063 |
0.496 |
|
2005 |
Hu Z, Dai Y, Prentki M, Chohnan S, Lane MD. A role for hypothalamic malonyl-CoA in the control of food intake. The Journal of Biological Chemistry. 280: 39681-3. PMID 16219771 DOI: 10.1074/Jbc.C500398200 |
0.497 |
|
2005 |
Cha SH, Hu Z, Chohnan S, Lane MD. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 102: 14557-62. PMID 16203972 DOI: 10.1073/Pnas.0507300102 |
0.475 |
|
2005 |
Dowell P, Hu Z, Lane MD. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annual Review of Biochemistry. 74: 515-34. PMID 15952896 DOI: 10.1146/Annurev.Biochem.73.011303.074027 |
0.474 |
|
2005 |
Hu Z, Cha SH, van Haasteren G, Wang J, Lane MD. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proceedings of the National Academy of Sciences of the United States of America. 102: 3972-7. PMID 15728730 DOI: 10.1073/Pnas.0500619102 |
0.488 |
|
2004 |
Cha SH, Hu Z, Lane MD. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3. Biochemical and Biophysical Research Communications. 317: 301-8. PMID 15063757 DOI: 10.1016/J.Bbrc.2004.03.026 |
0.485 |
|
2003 |
Hu Z, Cha SH, Chohnan S, Lane MD. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proceedings of the National Academy of Sciences of the United States of America. 100: 12624-9. PMID 14532332 DOI: 10.1073/Pnas.1834402100 |
0.49 |
|
Show low-probability matches. |